Treatment Sequencing in HER2+ mBC

 

SABCS 2021 Conference Coverage on VuMedi
N

SABCS 2021 Updated Results of Tucatinib vs. Placebo Added to Trastuzumab & Capecitabine for Previously Treated HER2+ MBC With Brain Mets: HER2CLIMB Study

By SABCS 2021 Conference Coverage on VuMedi FEATURING Nancy Lin
By SABCS 2021 Conference Coverage on VuMedi FEATURING Nancy Lin
963 views
January 10, 2022
0 Comments
Login to view comments. Click here to Login
Treatment Sequencing in HER2+ mBC
31:50
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2022

New Approaches in the Management of HER2+ Breast Cancers

Feat. S. Hurvitz
20:08
Memorial Sloan Kettering Cancer Center

HER2- Directed Targeted Agents for Brain Metastasis in Metastatic Br…

Feat. N. Iyengar
25:57
V.K. Gadi

2022 Updates in HER2+ mBC

14:00
Mridula George

Treatment Options in HER2+ Breast Cancer

07:02
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Updated Results of Tucatinib vs. Placebo Added to Trastuz…

Feat. N. Lin
09:07
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 on MRI Screening vs. SYMptom-Directed Surveillance for Br…

Feat. K. Jerzak
21:23
Stanford Medicine

Brain Metastases Are Now More Treatable in HER2+ Metastatic Breast C…

Feat. M. Pegram
14:14
Naomi Dempsey

Recognizing Common Symptoms in HER2+ Metastatic Breast Cancer

22:51
NYU Langone

Case Presentation on HER2+ Breast Cancer: Adapting Patient Care to a…

Feat. D. Marks